Powerful Tools for In vitro Fluorescent Imaging in Cancer Research
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
United States of America
01 October 2015
|Description:||ImmunoChemistry Technologies offers multiple tools for fluorescent imaging in the context of cancer research and oncology. ICT’s in vitro cell-based apoptosis assays allow biomedical researchers to investigate biological systems and the effects of disease and treatment. In this presentation, learn how to quantify caspase activity in vitro, monitor caspases and cathepsins, measure mitochondrial membrane potential, quantify necrosis and apoptosis, and detect serine protease activity. Ultimately, these various assay kits enable cancer researchers to evaluate drug treatment, monitor side-effects, and calculate dose-response|
Optional / Voluntary
Students, Researchers, Regulators and policy-makers, Teachers and educators, Technicians, Managers, Scientific officers / Project managers, Professionals (e.g. veterinarians), General public
Academia, Industry, Governmental bodies, Contract Research Organizations (CROs), Consulting, SMEs
University (Bachelor), University (Master), University (Doctoral education), Postdoctoral (teaching and research), Continuing Professional Development
In vitro methods
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
FLICA (Fluorescent labeled inhibitor of caspases)
FLISP (Fluorescent labeled inhibitors of serine proteases)
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!Please contact us by email if you have any questions.